Qiagen NV (NYSE: QGEN)’s stock price has gone decline by -0.92 in comparison to its previous close of 42.21, however, the company has experienced a -2.06% decrease in its stock price over the last five trading days. Zacks Investment Research reported 2024-03-26 that With QIAGEN’s (QGEN) QIAstat-Dx Analyzer 2.0’s integration of remote access, central and regional laboratories may work together efficiently, particularly when it comes to decentralized testing.
Is It Worth Investing in Qiagen NV (NYSE: QGEN) Right Now?
The price-to-earnings ratio for Qiagen NV (NYSE: QGEN) is above average at 27.41x. The 36-month beta value for QGEN is also noteworthy at 0.42. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 7 rating it as “hold,” and 0 rating it as “sell.”
The public float for QGEN is 220.29M, and at present, short sellers hold a 1.49% of that float. The average trading volume of QGEN on April 03, 2024 was 1.25M shares.
QGEN’s Market Performance
QGEN stock saw a decrease of -2.06% in the past week, with a monthly decline of -4.85% and a quarterly a decrease of -4.18%. The volatility ratio for the week is 1.46%, and the volatility levels for the last 30 days are 1.32% for Qiagen NV (QGEN). The simple moving average for the past 20 days is -4.36% for QGEN’s stock, with a -2.25% simple moving average for the past 200 days.
Analysts’ Opinion of QGEN
Many brokerage firms have already submitted their reports for QGEN stocks, with Wells Fargo repeating the rating for QGEN by listing it as a “Equal Weight.” The predicted price for QGEN in the upcoming period, according to Wells Fargo is $44 based on the research report published on December 19, 2023 of the previous year 2023.
Goldman gave a rating of “Buy” to QGEN, setting the target price at $50 in the report published on December 07th of the previous year.
QGEN Trading at -4.19% from the 50-Day Moving Average
After a stumble in the market that brought QGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.31% of loss for the given period.
Volatility was left at 1.32%, however, over the last 30 days, the volatility rate increased by 1.46%, as shares sank -5.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.89% lower at present.
During the last 5 trading sessions, QGEN fell by -2.22%, which changed the moving average for the period of 200-days by -10.37% in comparison to the 20-day moving average, which settled at $43.62. In addition, Qiagen NV saw -3.69% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for QGEN
Current profitability levels for the company are sitting at:
- 0.24 for the present operating margin
- 0.64 for the gross margin
The net margin for Qiagen NV stands at 0.17. The total capital return value is set at 0.09. Equity return is now at value 9.38, with 5.50 for asset returns.
Based on Qiagen NV (QGEN), the company’s capital structure generated 0.29 points at debt to capital in total, while cash flow to debt ratio is standing at 0.3. The debt to equity ratio resting at 0.4. The interest coverage ratio of the stock is 8.73.
Currently, EBITDA for the company is 650.58 million with net debt to EBITDA at 1.32. When we switch over and look at the enterprise to sales, we see a ratio of 5.19. The receivables turnover for the company is 3.81for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.99.
Conclusion
In summary, Qiagen NV (QGEN) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
